Skip to Main Content

Paper Details

The Impact of Preclinical High Potent P2Y Inhibitors on Decision Making at Discharge and Clinical Outcomes in Patients with Acute Coronary Syndrome.
0
2023
ACS, Acute Coronary Syndrome, P2Y, Patients, Purinergic signaling receptor Y, ST-elevation myocardial infarction, STEMI, acute coronary syndrome, cardiovascular death, patient, patients, prasugrel, ticagrelor
Author NameAffiliation
Christian HengstenbergMedical University of Vienna
  • 1 - 1

Datasets

Release 1.2